Literature DB >> 16498407

Progressively impaired proteasomal capacity during terminal plasma cell differentiation.

Simone Cenci1, Alexandre Mezghrani, Paolo Cascio, Giada Bianchi, Fulvia Cerruti, Anna Fra, Hugues Lelouard, Silvia Masciarelli, Laura Mattioli, Laura Oliva, Andrea Orsi, Elena Pasqualetto, Philippe Pierre, Elena Ruffato, Luigina Tagliavacca, Roberto Sitia.   

Abstract

After few days of intense immunoglobulin (Ig) secretion, most plasma cells undergo apoptosis, thus ending the humoral immune response. We asked whether intrinsic factors link plasma cell lifespan to Ig secretion. Here we show that in the late phases of plasmacytic differentiation, when antibody production becomes maximal, proteasomal activity decreases. The excessive load for the reduced proteolytic capacity correlates with accumulation of polyubiquitinated proteins, stabilization of endogenous proteasomal substrates (including Xbp1s, IkappaBalpha, and Bax), onset of apoptosis, and sensitization to proteasome inhibitors (PI). These events can be reproduced by expressing Ig-mu chain in nonlymphoid cells. Our results suggest that a developmental program links plasma cell death to protein production, and help explaining the peculiar sensitivity of normal and malignant plasma cells to PI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16498407      PMCID: PMC1409720          DOI: 10.1038/sj.emboj.7601009

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  59 in total

Review 1.  Analysis of apoptosis by laser scanning cytometry.

Authors:  E Bedner; X Li; W Gorczyca; M R Melamed; Z Darzynkiewicz
Journal:  Cytometry       Date:  1999-03-01

Review 2.  Degradation of cell proteins and the generation of MHC class I-presented peptides.

Authors:  K L Rock; A L Goldberg
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 3.  Building an antibody factory: a job for the unfolded protein response.

Authors:  Joseph W Brewer; Linda M Hendershot
Journal:  Nat Immunol       Date:  2005-01       Impact factor: 25.606

4.  Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells.

Authors:  Ferry Ossendorp; Nathalie Fu; Marcel Camps; Francesca Granucci; Sam J P Gobin; Peter J van den Elsen; Danita Schuurhuis; Gosse J Adema; Grayson B Lipford; Tomoki Chiba; Alice Sijts; Peter-M Kloetzel; Paola Ricciardi-Castagnoli; Cornelis J M Melief
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

5.  Distinct short-lived and long-lived antibody-producing cell populations.

Authors:  F Ho; J E Lortan; I C MacLennan; M Khan
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

6.  Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.

Authors:  L Meng; R Mohan; B H Kwok; M Elofsson; N Sin; C M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

7.  Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome.

Authors:  L Lin; G N DeMartino; W C Greene
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

8.  Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.

Authors:  C Johnson-Léger; J R Christenson; M Holman; G G Klaus
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

9.  IgM polymerization inhibits the Golgi-mediated processing of the mu-chain carboxy-terminal glycans.

Authors:  M M Cals; S Guenzi; S Carelli; T Simmen; A Sparvoli; R Sitia
Journal:  Mol Immunol       Date:  1996-01       Impact factor: 4.407

10.  Quality control of ER synthesized proteins: an exposed thiol group as a three-way switch mediating assembly, retention and degradation.

Authors:  A M Fra; C Fagioli; D Finazzi; R Sitia; C M Alberini
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

View more
  55 in total

1.  Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.

Authors:  Simona Zompi; Brian H Santich; P Robert Beatty; Eva Harris
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

Review 2.  Proteasome inhibitors: an expanding army attacking a unique target.

Authors:  Alexei F Kisselev; Wouter A van der Linden; Herman S Overkleeft
Journal:  Chem Biol       Date:  2012-01-27

3.  Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.

Authors:  Chia Chi Sun; David A Thorley-Lawson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

Review 4.  Cellular stress response pathways and ageing: intricate molecular relationships.

Authors:  Nikos Kourtis; Nektarios Tavernarakis
Journal:  EMBO J       Date:  2011-05-17       Impact factor: 11.598

5.  Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis.

Authors:  Yujia Wang; Lushuang Xu; Yang Liu; Yuzhe Hu; Qiang Shi; Lixue Jin; Lijun Yang; Pingzhang Wang; Kunshan Zhang; Xiaojun Huang; Qing Ge; Jin Lu
Journal:  Int J Hematol       Date:  2020-10-10       Impact factor: 2.490

6.  Molecular mechanisms of acquired proteasome inhibitor resistance.

Authors:  Andrew J Kale; Bradley S Moore
Journal:  J Med Chem       Date:  2012-10-03       Impact factor: 7.446

7.  Plasma cells require autophagy for sustainable immunoglobulin production.

Authors:  Niccolò Pengo; Maria Scolari; Laura Oliva; Enrico Milan; Federica Mainoldi; Andrea Raimondi; Claudio Fagioli; Arianna Merlini; Elisabetta Mariani; Elena Pasqualetto; Ugo Orfanelli; Maurilio Ponzoni; Roberto Sitia; Stefano Casola; Simone Cenci
Journal:  Nat Immunol       Date:  2013-01-27       Impact factor: 25.606

8.  Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo.

Authors:  Claire M Edwards; Seint T Lwin; Jessica A Fowler; Babatunde O Oyajobi; Junling Zhuang; Andreia L Bates; Gregory R Mundy
Journal:  Am J Hematol       Date:  2009-05       Impact factor: 10.047

9.  The unfolded protein response of B-lymphocytes: PERK-independent development of antibody-secreting cells.

Authors:  Jennifer N Gass; Hao-Yuan Jiang; Ronald C Wek; Joseph W Brewer
Journal:  Mol Immunol       Date:  2007-09-05       Impact factor: 4.407

10.  Stress Regulates Aquaporin-8 Permeability to Impact Cell Growth and Survival.

Authors:  Iria Medraño-Fernandez; Stefano Bestetti; Milena Bertolotti; Gerd P Bienert; Cinzia Bottino; Umberto Laforenza; Anna Rubartelli; Roberto Sitia
Journal:  Antioxid Redox Signal       Date:  2016-04-19       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.